Literature DB >> 28081442

Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice.

Annie Elong Ngono1, Edward A Vizcarra1, William W Tang1, Nicholas Sheets1, Yunichel Joo1, Kenneth Kim1, Matthew J Gorman2, Michael S Diamond2, Sujan Shresta3.   

Abstract

CD8+ T cells may play a dual role in protection against and pathogenesis of flaviviruses, including Zika virus (ZIKV). We evaluated the CD8+ T cell response in ZIKV-infected LysMCre+IFNARfl/fl C57BL/6 (H-2b) mice lacking the type I interferon receptor in a subset of myeloid cells. In total, 26 and 15 CD8+ T cell-reactive peptides for ZIKV African (MR766) and Asian (FSS13025) lineage strains, respectively, were identified and validated. CD8+ T cells from infected mice were polyfunctional and mediated cytotoxicity. Adoptive transfer of ZIKV-immune CD8+ T cells reduced viral burdens, whereas their depletion led to higher tissue burdens, and CD8-/- mice displayed higher mortality with ZIKV infection. Collectively, these results demonstrate that CD8+ T cells protect against ZIKV infection. Further, this study provides a T cell competent mouse model for investigating ZIKV-specific T cell responses.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8(+) T cell; LysMCre(+)IFNAR(fl/fl); Zika virus; epitope; mouse model; peptide

Mesh:

Substances:

Year:  2017        PMID: 28081442      PMCID: PMC5234855          DOI: 10.1016/j.chom.2016.12.010

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  60 in total

1.  Zika virus. II. Pathogenicity and physical properties.

Authors:  G W A DICK
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

Review 2.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

3.  CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.

Authors:  Raphaël M Zellweger; William W Tang; William E Eddy; Kevin King; Marisa C Sanchez; Sujan Shresta
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

4.  T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?

Authors:  Juthathip Mongkolsapaya; Thaneeya Duangchinda; Wanwisa Dejnirattisai; Sirijit Vasanawathana; Panisadee Avirutnan; Aroonroong Jairungsri; Nuanpan Khemnu; Nattaya Tangthawornchaikul; Pojchong Chotiyarnwong; Kanokwan Sae-Jang; Michael Koch; Yvonne Jones; Andrew McMichael; Xiaoning Xu; Prida Malasit; Gavin Screaton
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

5.  Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes.

Authors:  Allison Imrie; Janet Meeks; Alexandra Gurary; Munkhzul Sukhbataar; Paul Kitsutani; Paul Effler; Zhengshan Zhao
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

6.  Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013.

Authors:  E Oehler; L Watrin; P Larre; I Leparc-Goffart; S Lastere; F Valour; L Baudouin; Hp Mallet; D Musso; F Ghawche
Journal:  Euro Surveill       Date:  2014-03-06

7.  Male-to-Male Sexual Transmission of Zika Virus--Texas, January 2016.

Authors:  D Trew Deckard; Wendy M Chung; John T Brooks; Jessica C Smith; Senait Woldai; Morgan Hennessey; Natalie Kwit; Paul Mead
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-04-15       Impact factor: 17.586

Review 8.  T-cell immunity to infection with dengue virus in humans.

Authors:  Daniela Weiskopf; Alessandro Sette
Journal:  Front Immunol       Date:  2014-03-07       Impact factor: 7.561

9.  Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.

Authors:  Amelia K Pinto; James D Brien; Chia-Ying Kao Lam; Syd Johnson; Cindy Chiang; John Hiscott; Vanessa V Sarathy; Alan D Barrett; Sujan Shresta; Michael S Diamond
Journal:  mBio       Date:  2015-09-15       Impact factor: 7.867

10.  Characterization of a Novel Murine Model to Study Zika Virus.

Authors:  Shannan L Rossi; Robert B Tesh; Sasha R Azar; Antonio E Muruato; Kathryn A Hanley; Albert J Auguste; Rose M Langsjoen; Slobodan Paessler; Nikos Vasilakis; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

View more
  129 in total

1.  Persistent Zika Virus Clinical Susceptibility despite Reduced Viral Burden in Mice with Expanded Virus-Specific CD8+ T Cells Primed by Recombinant Listeria monocytogenes.

Authors:  Ashley R Burg; John J Erickson; Lucien H Turner; Giang Pham; Jeremy M Kinder; Sing Sing Way
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

Review 2.  Maternal-Fetal Transmission of Zika Virus: Routes and Signals for Infection.

Authors:  Bin Cao; Michael S Diamond; Indira U Mysorekar
Journal:  J Interferon Cytokine Res       Date:  2017-04-12       Impact factor: 2.607

Review 3.  Animal Models of Zika Virus Infection, Pathogenesis, and Immunity.

Authors:  Thomas E Morrison; Michael S Diamond
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

4.  Zika Virus Causes Acute and Chronic Prostatitis in Mice and Macaques.

Authors:  Jacques Halabi; Brett W Jagger; Vanessa Salazar; Emma S Winkler; James P White; Peter A Humphrey; Alec J Hirsch; Daniel N Streblow; Michael S Diamond; Kelle Moley
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

5.  Host response: Cross-fit T cells battle Zika virus.

Authors:  Matthew Collins; Aravinda de Silva
Journal:  Nat Microbiol       Date:  2017-05-25       Impact factor: 17.745

Review 6.  The continued threat of emerging flaviviruses.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Nat Microbiol       Date:  2020-05-04       Impact factor: 17.745

Review 7.  Overview on the Current Status of Zika Virus Pathogenesis and Animal Related Research.

Authors:  Shashank S Pawitwar; Supurna Dhar; Sneham Tiwari; Chet Raj Ojha; Jessica Lapierre; Kyle Martins; Alexandra Rodzinski; Tiyash Parira; Iru Paudel; Jiaojiao Li; Rajib Kumar Dutta; Monica R Silva; Ajeet Kaushik; Nazira El-Hage
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-25       Impact factor: 4.147

Review 8.  Taking the defensive: Immune control of Zika virus infection.

Authors:  James R Bowen; Matthew G Zimmerman; Mehul S Suthar
Journal:  Virus Res       Date:  2017-09-01       Impact factor: 3.303

Review 9.  Zika virus vaccines: immune response, current status, and future challenges.

Authors:  Justin M Richner; Michael S Diamond
Journal:  Curr Opin Immunol       Date:  2018-05-10       Impact factor: 7.486

10.  A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika.

Authors:  Jesse H Erasmus; Amit P Khandhar; Jeff Guderian; Brian Granger; Jacob Archer; Michelle Archer; Emily Gage; Jasmine Fuerte-Stone; Elise Larson; Susan Lin; Ryan Kramer; Rhea N Coler; Christopher B Fox; Dan T Stinchcomb; Steven G Reed; Neal Van Hoeven
Journal:  Mol Ther       Date:  2018-08-02       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.